Annual Total Expenses
$153.65 M
-$4.30 M-2.72%
31 December 2023
Summary:
Protagonist Therapeutics annual total expenses is currently $153.65 million, with the most recent change of -$4.30 million (-2.72%) on 31 December 2023. During the last 3 years, it has risen by +$450.00 thousand (+0.29%). PTGX annual total expenses is now -2.72% below its all-time high of $157.95 million, reached on 31 December 2022.PTGX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$46.13 M
+$3.17 M+7.37%
30 September 2024
Summary:
Protagonist Therapeutics quarterly total expenses is currently $46.13 million, with the most recent change of +$3.17 million (+7.37%) on 30 September 2024. Over the past year, it has increased by +$9.18 million (+24.84%). PTGX quarterly total expenses is now -5.17% below its all-time high of $48.64 million, reached on 31 March 2024.PTGX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Total Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +24.8% |
3 y3 years | +0.3% | +1.1% |
5 y5 years | +90.3% | +130.4% |
PTGX Total Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -2.7% | +0.3% | -5.2% | +42.8% |
5 y | 5 years | -2.7% | +90.3% | -5.2% | +130.4% |
alltime | all time | -2.7% | +1548.8% | -5.2% | +1615.4% |
Protagonist Therapeutics Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $46.13 M(+7.4%) |
June 2024 | - | $42.96 M(-11.7%) |
Mar 2024 | - | $48.64 M(+31.6%) |
Dec 2023 | $153.65 M(-2.7%) | $36.95 M(-3.6%) |
Sept 2023 | - | $38.33 M(-9.5%) |
June 2023 | - | $42.35 M(+17.6%) |
Mar 2023 | - | $36.02 M(-1.4%) |
Dec 2022 | $157.95 M(+3.1%) | $36.52 M(+13.0%) |
Sept 2022 | - | $32.30 M(-23.6%) |
June 2022 | - | $42.30 M(-9.7%) |
Mar 2022 | - | $46.83 M(+2.6%) |
Dec 2021 | $153.20 M(+64.5%) | $45.63 M(+3.2%) |
Sept 2021 | - | $44.21 M(+33.4%) |
June 2021 | - | $33.15 M(+9.7%) |
Mar 2021 | - | $30.21 M(+23.4%) |
Dec 2020 | $93.14 M(+15.3%) | $24.48 M(+17.2%) |
Sept 2020 | - | $20.89 M(-14.5%) |
June 2020 | - | $24.43 M(+4.7%) |
Mar 2020 | - | $23.34 M(+16.6%) |
Dec 2019 | $80.75 M | $20.02 M(-6.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2019 | - | $21.31 M(-8.2%) |
June 2019 | - | $23.22 M(+43.3%) |
Mar 2019 | - | $16.21 M(-8.8%) |
Dec 2018 | $73.19 M(+26.3%) | $17.77 M(+14.6%) |
Sept 2018 | - | $15.51 M(-25.9%) |
June 2018 | - | $20.91 M(+10.0%) |
Mar 2018 | - | $19.01 M(+28.5%) |
Dec 2017 | $57.96 M(+77.4%) | $14.79 M(+7.5%) |
Sept 2017 | - | $13.76 M(-9.1%) |
June 2017 | - | $15.13 M(+6.0%) |
Mar 2017 | - | $14.27 M(+25.2%) |
Dec 2016 | $32.67 M(+120.8%) | $11.40 M(+59.7%) |
Sept 2016 | - | $7.14 M(+0.7%) |
June 2016 | - | $7.09 M(+0.7%) |
Mar 2016 | - | $7.04 M(+40.8%) |
Dec 2015 | $14.79 M(+58.8%) | $5.00 M(+24.4%) |
Sept 2015 | - | $4.02 M(+30.4%) |
June 2015 | - | $3.08 M(+14.7%) |
Mar 2015 | - | $2.69 M |
Dec 2014 | $9.32 M | - |
FAQ
- What is Protagonist Therapeutics annual total expenses?
- What is the all time high annual total expenses for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly total expenses year-on-year change?
What is Protagonist Therapeutics annual total expenses?
The current annual total expenses of PTGX is $153.65 M
What is the all time high annual total expenses for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual total expenses is $157.95 M
What is Protagonist Therapeutics quarterly total expenses?
The current quarterly total expenses of PTGX is $46.13 M
What is the all time high quarterly total expenses for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly total expenses is $48.64 M
What is Protagonist Therapeutics quarterly total expenses year-on-year change?
Over the past year, PTGX quarterly total expenses has changed by +$9.18 M (+24.84%)